BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

Biotechnology

Healthcare
$7.32 +1.02%

+$0.09 today

Market cap
$1.88B
Beta
0.56
P/E (TTM)
-4.8
EPS (TTM)
-$1.89
52W Low $6.00High $10.32

Volume 3.78M

Average 4.85M

Price history

BioCryst Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+4.13%

Period high

$11.11

Period low

$6.24

Latest

$7.32

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 7, 2026Aug 7, 2026
10-QAug 5, 2026Aug 5, 2026
8-KAug 5, 2026Aug 5, 2026
S-8Aug 5, 2026Aug 5, 2026
8-K/AAug 4, 2026Aug 4, 2026
8-KJun 29, 2026Jun 29, 2026

Competitors

Who does BioCryst Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BCRX's filings, answered from its disclosures.

What is the latest BCRX filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does BCRX have?

Intrinsic Alpha currently shows 20 recent filings for BCRX.